Rationale and protocol of a trial for prevention of diabetic atherosclerosis by using antiplatelet drugs: study of Diabetic Atherosclerosis Prevention by Cilostazol (DAPC study)

<p>Abstract</p> <p>Background</p> <p>Secondary treatment of arteriosclerosis may be applicable for the primary prevention of atherosclerosis in diabetic patients. This prospective, 2-year follow-up study was designed to determine the efficacy and safety of antiplatelet...

Full description

Bibliographic Details
Main Authors: Kawamori Ryuzo, Kim Young-Seol, Yamasaki Yoshimitsu
Format: Article
Language:English
Published: BMC 2006-08-01
Series:Cardiovascular Diabetology
Online Access:http://www.cardiab.com/content/5/1/16